Literature DB >> 18815729

Rhodamine-loaded poly(lactic-co-glycolic acid) nanoparticles for investigation of in vitro interactions with breast cancer cells.

Tania Betancourt1, Kunal Shah, Lisa Brannon-Peppas.   

Abstract

Nanoparticle-based drug delivery systems are considered promising for the delivery of imaging agents and drugs for the detection and treatment of illnesses, including cancer. Investigation of nanoparticle interactions with the diseased cells can lead to better designs. In this work, poly(lactic-co-glycolic acid) nanoparticles loaded with rhodamine 6G were prepared by nanoprecipitation with high encapsulation efficiency. In vitro release studies demonstrated that rhodamine escaped from the nanoparticles at a very slow rate at physiological pH, thus making it ideal for imaging studies. At acidic pH this agent was released quickly, suggesting charge interactions between the polymer and rhodamine. Microscopy and flow cytometry studies show higher uptake in MDA-MB-231 breast cancer cells when exposed to rhodamine-loaded nanoparticles than to rhodamine in solution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815729     DOI: 10.1007/s10856-008-3594-z

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  30 in total

1.  Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.

Authors:  Jayanth Panyam; Sanjeeb K Sahoo; Swayam Prabha; Tom Bargar; Vinod Labhasetwar
Journal:  Int J Pharm       Date:  2003-08-27       Impact factor: 5.875

Review 2.  Controlled ring-opening polymerization of lactide and glycolide.

Authors:  Odile Dechy-Cabaret; Blanca Martin-Vaca; Didier Bourissou
Journal:  Chem Rev       Date:  2004-12       Impact factor: 60.622

Review 3.  PEGylated nanoparticles for biological and pharmaceutical applications.

Authors:  Hidenori Otsuka; Yukio Nagasaki; Kazunori Kataoka
Journal:  Adv Drug Deliv Rev       Date:  2003-02-24       Impact factor: 15.470

4.  Rhodamine 6G. A potent inhibitor of mitochondrial oxidative phosphorylation.

Authors:  A R Gear
Journal:  J Biol Chem       Date:  1974-06-10       Impact factor: 5.157

5.  Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.

Authors:  Derek W Bartlett; Mark E Davis
Journal:  Bioconjug Chem       Date:  2007-02-28       Impact factor: 4.774

6.  Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.

Authors:  M R Green; G M Manikhas; S Orlov; B Afanasyev; A M Makhson; P Bhar; M J Hawkins
Journal:  Ann Oncol       Date:  2006-06-01       Impact factor: 32.976

7.  Microplate screening of the differential effects of test agents on Hoechst 33342, rhodamine 123, and rhodamine 6G accumulation in breast cancer cells that overexpress P-glycoprotein.

Authors:  Jeffrey G Sarver; Wieslaw A Klis; James P Byers; Paul W Erhardt
Journal:  J Biomol Screen       Date:  2002-02

8.  Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers.

Authors:  S Stolnik; S E Dunn; M C Garnett; M C Davies; A G Coombes; D C Taylor; M P Irving; S C Purkiss; T F Tadros; S S Davis
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

9.  Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats.

Authors:  D V Bazile; C Ropert; P Huve; T Verrecchia; M Marlard; A Frydman; M Veillard; G Spenlehauer
Journal:  Biomaterials       Date:  1992       Impact factor: 12.479

10.  Isolation and characterization of an adriamycin-resistant breast tumor cell line.

Authors:  S L Schneider; S A Fuqua; K V Speeg; A K Tandon; W L McGuire
Journal:  In Vitro Cell Dev Biol       Date:  1990-06
View more
  12 in total

1.  Preparation and characterization of amphiphilic poly-N-vinylpyrrolidone nanoparticles containing indomethacin.

Authors:  Andrey N Kuskov; Anna A Voskresenskaya; Anastasiya V Goryachaya; Alexander A Artyukhov; Mikhail I Shtilman; Aristidis M Tsatsakis
Journal:  J Mater Sci Mater Med       Date:  2010-02-23       Impact factor: 3.896

2.  Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery.

Authors:  Thejani E Rajapaksa; Mary Stover-Hamer; Xiomara Fernandez; Holly A Eckelhoefer; David D Lo
Journal:  J Control Release       Date:  2009-11-05       Impact factor: 9.776

3.  Peptide-functionalized nanogels for targeted siRNA delivery.

Authors:  William H Blackburn; Erin B Dickerson; Michael H Smith; John F McDonald; L Andrew Lyon
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

4.  Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents.

Authors:  Amber L Doiron; Kimberly A Homan; Stanislav Emelianov; Lisa Brannon-Peppas
Journal:  Pharm Res       Date:  2008-11-26       Impact factor: 4.200

5.  OX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery ability.

Authors:  Hanmei Bao; Xu Jin; Ling Li; Feng Lv; Tianjun Liu
Journal:  J Mater Sci Mater Med       Date:  2012-05-09       Impact factor: 3.896

6.  Synthesis, characterization and transfection of a novel folate-targeted multipolymeric nanoparticles for gene delivery.

Authors:  Yu Nie; Zhirong Zhang; Li Li; Kui Luo; Hong Ding; Zhongwei Gu
Journal:  J Mater Sci Mater Med       Date:  2009-05-06       Impact factor: 3.896

7.  Surface analysis of PEGylated nano-shields on nanoparticles installed by hydrophobic anchors.

Authors:  M F Ebbesen; B Whitehead; B Ballarin-Gonzalez; P Kingshott; K A Howard
Journal:  Pharm Res       Date:  2013-04-12       Impact factor: 4.200

8.  A Facile and General Method for the Encapsulation of Different Types of Imaging Contrast Agents Within Micrometer-Sized Polymer Beads.

Authors:  Meng-Yi Bai; Christine H Moran; Lei Zhang; Changjun Liu; Yu Zhang; Lihong V Wang; Younan Xia
Journal:  Adv Funct Mater       Date:  2011-12-12       Impact factor: 18.808

9.  Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer.

Authors:  Armando Lucero-Acuña; Justin J Jeffery; Edward R Abril; Raymond B Nagle; Roberto Guzman; Mark D Pagel; Emmanuelle J Meuillet
Journal:  Int J Nanomedicine       Date:  2014-12-03

10.  New injectable two-step forming hydrogel for delivery of bioactive substances in tissue regeneration.

Authors:  Edgar Pérez-Herrero; Patricia García-García; Jaime Gómez-Morales; Matias Llabrés; Araceli Delgado; Carmen Évora
Journal:  Regen Biomater       Date:  2019-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.